Market Tracker

02/11 7:49am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

12.48
Delayed Data
As of Feb 10
 +0.35 / +2.89%
Today’s Change
8.32
Today|||52-Week Range
23.30
-7.14%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close12.13
Today’s open12.31
Day’s range12.20 - 13.27
Volume911,098
Average volume (3 months)833,897
Market cap$593.4M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-35.27%
Earnings growth (next 5 years)+72.00%
Revenue growth (last year)+915.43%
P/E ratio55.4
Price/Sales3.44
Price/Book7.31

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+0.79+3.84%
TBPHTheravance Biopharma...-0.55-3.37%
MACKMerrimack Pharmaceut...-0.03-0.55%
MGNXMacroGenics Inc-0.15-0.93%
Data as of 02/10/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts